Despite a remarkable increase in the depth of our understanding and management of breast cancer in the past 50 years, the disease is still a major public health problem worldwide and poses significant challenges. With the advent of modern medicine, we have come a long way.
Indeed, when the sequence of the human genome was published in 2001, studies showed that only about 1.2% encodes proteins, the rest being deemed "non-coding." It was later shown that the genome is pervasively transcribed into many ncRNAs, but their functionality remained controversial.
CRISPR (pronounced “crisper”) as a genome-editing tool is currently one of the hottest topics of research in the biological sciences. This is very much evident in the fact that in 2011, there were fewer than 100 published papers on CRISPR
The thoughts of another pandemic while already in the grips of one sends chills down our spines! So, without further ado, let us see if we can nip it in its bud. Although not contagious, unlike COVID-19